Back to Trials
NCT04278690NARecruiting

Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit

NYU Langone Health

Start Date

3/10/2021

Completion Date

2/1/2027

Summary

This is a randomized controlled study of parents of children to be discharged from the neonatal intensive care unit at Bellevue and Elmhurst hospitals. A total of 425 subjects will be recruited across two sites over preparatory phases and two primary study phases.

Detailed Description

Our overarching goal is to promote safe medication use/adherence for high-risk infants, by leveraging health literacy approaches and mobile technology to reinforce provider counseling and support parent medication management after discharge from the NICU. We will adapt/integrate evidence-based strategies studied in less complex populations, for this vulnerable group. The HELPix (Health Education and Literacy for Parents) pictogram-based intervention, developed by our team, incorporates these strategies, with sizeable improvements found in medication knowledge, dosing errors, and adherence in outpatient general pediatric settings, but to date, HELPix has not been studied in NICU settings

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. English or Spanish-speaking 2. 18 years of age and older 3. Child discharged home with a Rx for \>1 daily liquid medication (other than multivitamin) 4. Primary person who will administers child's medications. 5. Willingness and ability to participate Exclusion Criteria: 1. Does not have a working phone number 2. Does not have access to internet (via computer/smartphone) 3. Does not have a mobile phone that receives texts. 4. Not able to return to the hospital for their child's follow-up visit 5. Visual acuity worse than 20/50 according to the Rosenbaum Pocket Screener 6. Uncorrectable hearing impairment

Interventions

OTHER

HELPix

OTHER

HELPix+Tech

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Medication Administered in Error

Locations

NYU Langone Health

New York, New York 10016

United States